Australian medtech body calls for purchasing enquiry:
This article was originally published in Clinica
The Medical Industry Association of Australia is calling for an urgent enquiry into Commonwealth and State purchasing of medical products. The body is about to submit a report to the Industry Commission enquiry which is examining ways to enhance the development prospects of the medtech industry in Australia. The MIAA believes the enquiry must take full account of those companies not engaged in local manufacture. MIAA chairman Rob Gregg also called on industry to submit comments on the Commission's draft paper, which will be released in mid-July for public comment. The government deadline for the final report is February 24th, 1997.
You may also be interested in...
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.
The leading Korean pharma firm’s oral, third-generation EGFR-TKI is approved in the country, providing a new option for patients with advanced NSCLC and increasing hopes for global approvals given an ongoing global Phase III combination trial led by partner J&J.
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.